June 18, 2024Neuro-OncologyOpen Access

GCT-15. Clinical and Molecular Characterization of Infantile Central Nervous System Germ Cell Tumors

View Full Paper

Ask AI

Bookmark

Authors

KFKohei FukuokaKyushu University HTHirokazu TakamiUniversity of Tokyo Hospital KSKaishi SatomiNational Cancer Center Hospital East

Discussion

Member takes

Implication

Molecular analysis reveals divergent survival rates in infantile central nervous system germ cell tumors, highlighting diagnostic misclassification that alters clinical care.

Key Points

Infantile central nervous system germ cell tumors exhibit distinct clinical and molecular profiles, with histological subtypes determining long-term patient outcomes.
Overall survival at three years reached 100% in mixed lesions and dropped to 0% in embryonal tumors, demonstrating profound prognostic divergence across subtypes.
DNA methylation analysis using the Illumina Methylation EPIC array evaluated 43 pediatric patients, reclassifying four suspected cases as distinct embryonal tumors.
Highlights the necessity of routine genomic profiling to detect secondary teratomas and mapk pathway alterations, which may guide individualized therapeutic strategies.

Cite This Study

Fukuoka et al. (2024) studied this question.

synapsesocial.com/papers/68e64531b6db6435875d682d https://doi.org/10.1093/neuonc/noae064.270

View Full Paper

Ask AI

Bookmark

Implication

Molecular analysis reveals divergent survival rates in infantile central nervous system germ cell tumors, highlighting diagnostic misclassification that alters clinical care.

GCT-15. Clinical and Molecular Characterization of Infantile Central Nervous System Germ Cell Tumors

Discussion

Member takes

Implication

Key Points

Cite This Study

GCT-15. Clinical and Molecular Characterization of Infantile Central Nervous System Germ Cell Tumors

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider